|
1
|
Russo RAG and Katsicas MM: Takayasu
arteritis. Front Pediatr. 6(265)2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Arend WP, Michel BA, Bloch DA, Hunder GG,
Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie JT, Lightfoot
RW Jr, et al: The American college of rheumatology 1990 criteria
for the classification of Takayasu arteritis. Arthritis Rheum.
33:1129–1134. 1990.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Vaideeswar P and Deshpande JR: Pathology
of Takayasu arteritis: A brief review. Ann Pediatr Cardiol.
6:52–58. 2013.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Arnaud L, Haroche J, Mathian A, Gorochov G
and Amoura Z: Pathogenesis of Takayasu's arteritis: A 2011 update.
Autoimmun Rev. 11:61–67. 2011.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Kong X, Sun Y, Ma L, Chen H, Wei L, Wu W,
Ji Z, Ma L, Zhang Z, Zhang Z, et al: The critical role of IL-6 in
the pathogenesis of Takayasu arteritis. Clin Exp Rheumatol. 34
(Suppl):S21–S27. 2016.PubMed/NCBI
|
|
6
|
Wu G, Mahajan N and Dhawan V: Acknowledged
signatures of matrix metalloproteinases in Takayasu's. arteritis.
Biomed Res Int. 2014(827105)2014.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Tripathy NK, Chandran V, Garg NK, Sinha N
and Nityanand S: Soluble endothelial cell adhesion molecules and
their relationship to disease activity in Takayasu's arteritis. J
Rheumatol. 35:1842–1845. 2008.PubMed/NCBI
|
|
8
|
Kumar Chauhan S, Kumar Tripathy N, Sinha
N, Singh M and Nityanand S: Cellular and humoral immune responses
to mycobacterial heat shock protein-65 and its human homologue in
Takayasu's arteritis. Clin Exp Immunol. 138:547–553.
2004.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Chauhan SK, Tripathy NK and Nityanand S:
Antigenic targets and pathogenicity of anti-aortic endothelial cell
antibodies in Takayasu arteritis. Arthritis Rheum. 54:2326–2333.
2006.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Espinoza JL, Ai S and Matsumura I: New
insights on the pathogenesis of Takayasu arteritis: Revisiting the
microbial theory. Pathogens. 7(73)2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Misra DP, Wakhlu A, Agarwal V and Danda D:
Recent advances in the management of Takayasu arteritis. Int J
Rheum Dis. 22 (Suppl):60–68. 2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Keser G, Aksu K and Direskeneli H:
Takayasu arteritis: An update. Turk J Med Sci. 48:681–697.
2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Ataş N, Varan Ö, Babaoğlu H, Satiş H,
Bilici Salman R and Tufan A: Certolizumab pegol treatment in three
patients with Takayasu arteritis. Arch Rheumatol. 34:357–362.
2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Shao N, Jia H, Li Y and Li J: Curcumin
improves treatment outcome of Takayasu arteritis patients by
reducing TNF-α: A randomized placebo-controlled double-blind
clinical trial. Immunol Res. 65:969–974. 2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Shi G, Hua M, Xu Q and Ren T: Resveratrol
improves treatment outcome and laboratory parameters in patients
with Takayasu arteritis: A randomized double-blind and
placebo-controlled trial. Immunobiology. 222:164–168.
2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Matsuyama A, Sakai N, Ishigami M, Hiraoka
H and Yamashita S: Minocycline for the treatment of Takayasu
arteritis. Ann Intern Med. 143:394–395. 2005.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Mason JC: Surgical intervention and its
role in Takayasu arteritis. Best Pract Res Clin Rheumatol.
32:112–124. 2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Stancioiu F and Makk R: Post-stroke
recovery of motor function with a new combination of medicines-A
pilot study. EJMO. 3:167–181. 2019.
|
|
19
|
Jeong HS, Jung JH, Song GG, Choi SJ and
Hong SJ: Endovascular balloon angioplasty versus stenting in
patients with Takayasu arteritis: A meta-analysis. Medicine
(Baltimore). 96(e7558)2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Miyata T, Sato O, Koyama H Shigematsu H
and Tada Y: Long-term survival after surgical treatment of patients
with Takayasu's arteritis. Circulation. 108:1474–1480.
2003.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Stone GW, Sabik JF, Serruys PW, Simonton
CA, Généreux P, Puskas J, Kandzari DE, Morice MC, Lembo N, Brown WM
III, et al: Everolimus-eluting stents or bypass surgery for left
main coronary artery disease. N Engl J Med. 375:2223–2235.
2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Perera AH, Youngstein T, Gibbs RG, Jackson
JE, Wolfe JH and Mason JC: Optimizing the outcome of vascular
intervention for Takayasu arteritis. Br J Surg. 101:43–50.
2014.PubMed/NCBI View
Article : Google Scholar
|
|
23
|
Kim YW, Kim DI, Park YJ, Yang SS, Lee GY,
Kim DK, Kim K and Sung K: Surgical bypass vs endovascular treatment
for patients with supra-aortic arterial occlusive disease due to
Takayasu arteritis. J Vasc Surg. 55:693–700. 2012.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Labarca C, Makol A, Crowson CS, Kermani
TA, Matteson EL and Warrington KJ: Retrospective comparison of open
versus endovascular procedures for Takayasu arteritis. J Rheumatol.
43:427–432. 2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Arraes AE, de Souza AW, Mariz HA, Silva
NP, Torres IC, Pinto PN, Lima EN and Sato EI:
(18)F-Fluorodeoxyglucose positron emission tomography and serum
cytokines and matrix metalloproteinases in the assessment of
disease activity in Takayasu's arteritis. Rev Bras Reumatol Engl
Ed. 56:299–308. 2016.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Yoshida M, Zoshima T, Hara S, Mizushima I,
Fujii H, Yamada K, Sato Y, Harada K and Kawano M: A long-term
survival after surgical treatment for atypical aortic coarctation
complicating Takayasu arteritis with inactive disease at the
diagnosis: An appropriately treated autopsy case. Intern Med.
58:2241–2246. 2019.PubMed/NCBI View Article : Google Scholar
|
